410417, May 2021, doi: 10.1016/j.jsps.2021.04.001
eClinicalMedicine 2024;69:doi:10.1016/j.eclinm.2024.102475
The analysis led to generally consistent results, which were similar to the primary analysis between cohorts of new users of GLP-1RAs compared with new users of SGLT2 inhibitors, metformin or other second- or third-line medications
Mills S, Stanton C, Fitzgerald GF, Ross RP: Enhancing the stress responses of probiotics for a lifestyle from gut to product and back again
While Mounjaro offers a dual-agonist approach targeting both GLP-1 and GIP receptors, Wegovy has a well-established track record in the UK for sustainable weight management
As previously established, ALCAR successfully crosses the blood-brain barrier and donates its acetyl group to form Acetyl-CoA